
EASD 2025
Sustained Impact of Dapagliflozin on Epicardial Fat Thickness in Type 2 Diabetes: Insights from the DAPAHEART 4-Year Experience
The groundbreaking study was presented on Monday, September 15th, 2025

The groundbreaking study was presented on Monday, September 15th, 2025

The trial study was presented on Tuesday, September 16th, 2025

The research study was presented on Tuesday, September 16th, 2025

The comprehensive study was presented on Tuesday, September 16th, 2025

The comprehensive study was presented on Tuesday, September 16th, 2025

The trial study was presented on Monday, September 15th, 2025